|
|
Line 136: |
Line 136: |
| *[[Metaplastic carcinoma]]. | | *[[Metaplastic carcinoma]]. |
| *[[Neuroendocrine tumour]]. | | *[[Neuroendocrine tumour]]. |
| *Apocrine carcinoma - need 90% apocrine morphology,<ref name=Ref_BP217>{{Ref BP|217}}</ref> smaller tumours classically AR+, GCDFP-15+.<ref name=pmid16045781>{{Cite journal | last1 = Honma | first1 = N. | last2 = Takubo | first2 = K. | last3 = Akiyama | first3 = F. | last4 = Sawabe | first4 = M. | last5 = Arai | first5 = T. | last6 = Younes | first6 = M. | last7 = Kasumi | first7 = F. | last8 = Sakamoto | first8 = G. | title = Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. | journal = Histopathology | volume = 47 | issue = 2 | pages = 195-201 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02181.x | PMID = 16045781 }}</ref> | | *Apocrine carcinoma. |
| *Lipid-rich carcinoma. | | *Lipid-rich carcinoma. |
| *Secretory carcinoma. | | *Secretory carcinoma. |